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Quantitative Relation of Myocardial Infarct Size and Myocardial
Viability by Positron Emission Tomography to Left Ventricular
Ejection
Fraction and 3-Year Mortality With and
Without Revascularization
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Houston, Texas
Obfcdves . The purpose of this study was to determine the
clinical prognostic value, with and without revascularizatioa, of
the do* of ayocardial infarction and viability as measured by
positron emission tomography (PET) .
Backgnei nd. Poorly contracting but viable myocardium recov-
ere contractile performance after revascularfzation . However, the
quantitative relation among size of infarction and viability by
PET, ejection fraction and long-form survival with and without
revue in patients after myocardial Infarction has not
been previously reported .
Methods. Infarct size and viability Imaged by PET using
generator-produced rubidium-82 were quantified objectively by
automated software and related to coronary arterlography, left
ventricular ejection fraction, revascularization and 3-year mortal-
ity .
Results. Myocardial infarction or sear
;t23%
of the left
ventricle was associated with a 3-year mortality rate of 43%
versus that of 5% associated with scar <23% of the left ventricle
(p a 0.014). An ejection fraction t543% correlated with a 3-year
mortality rate of 38% compared with 6% for an ejection fraction
e43% (p ae 0.029) because Infarct size a!23% of the left ventricle
Reduced left ventricular ejection fraction in patients with
coronary artery disease is associated with a shortened sur-
vival time (1,2) .
However, impaired ventricular function
may be due to a permanent, fixed scar resulting from
myocardial infarction,
chronically underperfused, viable
"hibernating" myocatxlium
. or to acutely ischemic, viable
"stunned" myocardium after reperfusion-all identifiable by
positron emission tomography (PET)
(3-I7) . Viable myocar-
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was also associated with an ejection fraction t-41%. For patients
with a low ejection fraction (s43%) or large infaretslscar (-23%
of the left ventricle), ejection fraction value or infarct size did not
predict mortality . However, in patients with an ejection fraction
X43%, the absence of viable myocardlum in arterial zones at risk
was associated with a mortality rate of 63% versus 13% in
subjects with viable myocardium, a difference with only a 5 .9%
probability of occurring by chance alone (p = 0 .059).
For all
patients with viable myocardium in arterial zones at risk, the
mortality rate was 8%, and 80% had revaseularizatlon over 3
years. For patients with only fixed scar in arterial zones at risk,
the mortality rate was 50% versus 8% (p = 0
.018), and 40% had
revascular'sation, with no difference in mortality with or without
reva.scular:nation, thereby suggesting no benefit In this subgroup .
Conch+,ions . Size of scar and viable myocardium by PET in
arterial zones at risk In patients after myocardial infarction are
highly predictive of 3-year mortality, particularly in patients with
low ejection fraction, and identify
patients who are suitable
candidates for revascularization after myocardial infarction .
tJ Am Con Cardiol 1993;22:984-97)
dium identified by PET in poorly contracting segments
predicts improved function after revascularization (8-14) or
a high mortality rate in patients who do not have revascu-
larization (9) .
However, the relation of quantitative infarct size and
myocardial viability (or nonviability) to left ventricular ejec-
tion fraction and long-term mortality rate in patients after
myocardial infarction has not been reported
. Therefore, to
determine the prognostic value of measuring infarct size and
identifying viable (or nonviable) myocardium by
PET, we
followed up for 3 years a cohort of the first 35
patients
studied by PET for myocardial viability using generator-
produced rubidium-82, previously shovwn comparable to
cyclotron-produced F-l8 fluorodeoxyglucose for assessing
myocardial viability (15-18)
. Mortality during the 3-year
follow-up period was compared with potential predictors of
outcome obtained at entry to the study
. particularly left
ventricular ejection fraction, size of infarcllscar and myocar-
dial viability by PET in arterial zones at risk in those without
0735-1(97193/$6 .W
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revascularization and those who had revascularization by
coronary angioplasty or coronary artery bypass surgery .
Unique aspects of our study design include the objective,
automated quantitation of infarct size by PET, the use of
generator-produced rubidium-82 not requiring an on-site
cyclotron for assessing infarct sizelviability, the quantitative
relation of infarct size by PET to left ventricular ejection
fraction and to mortality and the long-term follow-up of
3 years. not previously reported . The results indicate that
size of myocardial infarction or scar and viability in arterial
zones at risk assessed by PET are good prognostic indicators
of mortality, particularly in patients with reduced left ven-
tricular ejection fraction, and provide an objective basis for
selecting patients for revascularization after myocardial in-
farction .
Methods
Study patients . A cohort of the first 35 patients studied by
the rubidium washout method for assessing myocardial
viability were followed up to determine mortality over
3 years (follow-up duration 105 patient-years) . Patients
were initially selected for the study by the following criteria :
1) previous recent or remote myocardial infarction evi-
denced by history, electrocardiogram (ECG), creatine ki-
nase isoenzymes and left ventricular angiography or coro-
nary arteriography, or both ; 2) hemodynamic stability
without dependency on intravenous inotropic agents or
aortic balloon pump support to undertake safely a 2- to 3-h
period of PET imaging ; 3) availability of appropriate positron
radiotracers and availability of time on the PET scanner for
protocol studies as opposed to clinical service studies ;
4) coronary arteriography and, when clinically appropriate,
left ventricular angiography ; 5) written, informed consent
approved by the Committee for the Protection of Human
Subjects of the University of Texas, the most updated
renewal approved on December 20, 1991; 6) permission of
the attending cardiologist to obtain a PET scan .
A mix of patients with old or new, silent or symptomatic
myocardial infarction were included in this pilot study . We
accepted all available subjects meeting the previous criteria
so that the study group resembled that seen in clinical
practice, where viability information on this full range of
patients is necessary. Furthermore, there was no difference
in predictive value of viability measurements, infarct size,
ejection fraction or prevalence of viability in arterial zones at
risk in patients with recent versus old myocardial infarction .
Therefore, the study included patients with acutely isch-
emic, hypokinetic, "stunned" myocardium as well as those
with chronically underperfused, hypokinetic "hibernating"
myocardium because both types of patients have hypo-
kinetic viable myocardium .
Of 35 patients studied, 22 were men and 13 were women
with a mean age of 54 years (range 36 to 80) . Nineteen had
acute myocardial infarction within 30 days of the PET study,
with a mean interval of 14 days (range 4 to 28 d) from the
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most recent clinical infarction to PET study . Sixteen had old
myocardial infarction, defined as >30 days before the PET
study, with a mean interval of 21 months (range 2 to 72) from
the clinical infarction to the PET study
. Of these 16 patients,
5 had a clinically silent cardiac event on the basis of severe
coronary artery stenosis or occlusion established by coro-
nary arteriography and corresponding wall motion abnor-
malities at rest by left ventricular angiography .
Coronary arteriography was performed in all patients,
predominantly by the percutaneous femoral approach to
correlate the anatomic distribution of coronary artery dis-
ease with regional PET abnormalities. Thirty-one patients
had left ventricular angiograms . Three of four patients who
did not undergo left ventriculography for clinical reasons
were studied with gated radionuclide ventriculography . Four
patients had undergone coronary artery bypass grafting, and
I I patients had undergone previous coronary angioplasty
before PET scans, thereby providing a necessary subgroup
with full reperfusion to areas having a varying extent of
myocardial infarction. The patency status of bypass grafts or
residual stenosis after coronary angioplasty was established
for each patient by arteriography before the patient entered
the study. This mix of a variety of patients with myocardial
infarction was essential for general clinical relevance .
Positron emission tomography . Patients were studied in a
nonfasted state after receiving 50 g of oral glucose (Glucola)
on arrival in the PET laboratory . Twelve standard ECG
lcads and a Dynamap blood pressure cuff were used for
monitoring each patient . Positron emission tomography was
performed as previously described (5-7,15,16,19-21) using
the University of Texas 9-slice tomograph with a recon-
structed resolution of 14 mm at full width half maximum .
Transmission images of 100 to 200 million counts were
obtained to correct for photon attenuation. Forty to 50 mCi
of rubidium-82 was infused intravenously from a
strontium-
82/rubidium-82
generator (Squibb) for 20 to 60 s, depending
on the age of the generator . Data collection of rubidium was
begun in list mode at 80 s (defined as 0 time of data
collection) after the beginning of the rubidium infusion to
allow for blood pool clearance and was continued through
360 s. Early and late PET images were reconstructed using
the Ist 15 to 110 s and 120 to 360 s of data, respectively .
After completion of rubidium imaging, 10 mCi of F-18
fluorodeoxyglucose was injected intravenously
. Forty-five
minutes later, F-18 fluorodeoxyglucose images were ac-
quired for 30 min . Each original 9-slice image set of paired
early and late rubidium data and late rubidium images
paired with the F-18 fluorodeoxyglucose image were refor-
matted into true short-axis, true long-axis and polar maps in
a paired side by side display . A relative ratio image of the
late to early rubidium polar maps was also displayed as a
ratio polar map for quantitative analysis, as previously
described (5-7,15,16).
Assessing viability and infarct size from rubidium kinetics
has been shown to be comparable to myocardial imaging
with F-18 fluorodeoxyglucose in
patients with myocardial
986
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infarction (5-7,15,16)
. In brief, on delivery by coronary flow
to myocardium after intravenous injection, the potassium
analogue rubidium-82 is trapped in the intracellular potas-
sium space of viable myocardial cells (22,23). However, if
the cells are necrotic, the delivered rubidium is not retained
because of loss of integirity of the intracellular potassium
space and washes out of the field. of view on serial PET
images
. Scar tissue does not have an intracellular potassium
space comparable to viable myocardium and therefore does
not take up rubidium to the same extent . Although this
laboratory first described combined dipyridamole perfusion
imaging with viability imaging (5), in this study perfusion
imaging after dipyridamole was not obtained because all
patients had known severity and distribution of coronary
artery disease established by arteriography .
Regional gaanthatbn of positron emission tomographic
Isu g . For purposes of objective, automated infarct sizing,
we used a previously demonstrated, simple model to quan-
tify the size of rubidium washout, where the percent of
infarcted, scarred or viable myocardium is determined from
to the ratio of activity on the late (S 2 ) to the early (S,) image,
corrected for background activity, as previously shown
(5-7,15,16,21-23) and confirmed by others (17,18) . For myo-
cardium with <50 viable tissue, the corresponding relative
ratio on the late/early ratio image is x0.825 when back-
ground on the late/early ratio image is accounted for, as
previously described (5,15,16) . The size of the infarct area
on the rubidium image was therefore automatically deter-
mined as the percent of the latelearly S 2IS, ratio image that
was <0.825. The size of the infarcted area on the F-l8
fluorodeoxyglucose image was also automatically deter-
mined as the percent of the F-l8 fluorodeoxyglucose polar
map display hat was <55% of maximal F-18 fluorodeoxy-
glucose uptake in that polar map, also previously reported
by our laboratory (5,15,16) and comparable to the threshold
method used by Bonow et al. (24) and Berry et al. (25) for
F-18 fluorodeoxyglucose images.
In addition to quantitative analysis by automated soft-
ware as previously described without visually drawn bound-
aries (5-7,15,16) . PET images were also visually interpreted
as previously described (5,15) by two experienced, indepen-
dent readers unaware of the clinical and arteriographic data .
Separately from objective, automated computer measure-
ments of infarct size, the readers visually estimated infarct
size and qualitatively evaluated type of rubidium washout
using paired early and late rubidium images to ensure against
potential artifacts in computer sizing of infarcts . The type of
rubidium washout was visually qualitatively classified as
types I' to V, as previously described (5). In brief, type I has
no defect in the early rubidium image but washes out to show
a mild, small defect on the late rubidium image ( :~!60% of
maximal activity). It indicates a small extent of necrosis,
with predominantly viable myocardium remaining . Type II
has a mild, modestly sized initial defect on the early rubid-
ium image that washes out to become more severe and larger
on the late rubidium image (50% to (41% of maximal activity)
but with sufficient remaining activity in the defect to indicate
substantial residual rubidium trapping . It indicates signifi-
cant necrosis but also substantial remaining viable myocar-
dium. Type III has a large, moderately severe (<50% of
maximal activity) defect on the initial rubidium image that
becomes very severe on the late rubidium image, with little
remaining trapped rubidium . It indicates predominant necro-
sis with little remaining viable myocardium .
Washout types I to 111 reflect progressively less viable
myocardium with larger and more severe infarction . Type IV
has a large, fixed, severe defect with very low initial activity,
comparable to background (<50% of maximal activity),
which Is too low for washout to be observed and indicates a
fixed transmural scar or necrosis. For type V, the late images
showed increased activity or "wash-in" on the late versus
the early image, with a rutia of >1 .0,
suggesting low flow with delayed rubidium delivery to myo-
cardium on the early image that is predominantly viable, as
evidenccd by substantial rubidium trapping on the late
image.
The readers visually evaluated the location of infarcted
regions on early and late rubidium images and on the F-18
fluorodeoxyglucose images . The infarcted areas were local-
ized in one or more of five regions of the heart (anterior,
apical, septal, lateral and inferior left ventricular walls) .
Finally, the readers compared the visual size and intensity of
the necrotic area based on rubidium washout images side by
side on the same display with that of F-18 fluorodeoxyglu-
cose images and classified these visual comparisons as
detects of rubidium <F-1S fluorodeoxyglucose ; rubidium =
F-18 fluorodeoxyglucose ; rubidium >F-18 fluorodeoxyglu-
cose. When there was disagreement between the readers,
the images were reviewed together to obtain consensus . To
ensure against one reader dominating the other, records of
changes in the final consensus reading were kept for each
reader.
Analysis of data. Infarct size, washout type and presence
of myocardial viability on rubidium and F-18 fluorodeoxy-
glucose images were compared with regard to location and
severity of left ventricular dysfunction on left ventricular
angiograms, location and severity of stenoses on coronary
arteriograms and mortality over the 3 years after the PET
study. Statistical analyses of the correlation between quan-
titative infarct size and ejection fraction were made by
nonlinear correlation (26) . Differences in mortality in subsets
of patients based on PET data were analyzed by the Fisher
exact test (27,28). with calculation of exact p values rather
than just significance or no significance .
Patients were analyzed individually for sufficient remain-
ing viable myocardium to determine candidates for potential
revascularization by coronary angioplasty or coronary ar-
tery bypass surgery on the basis of PET viability data
correlated with a detailed individual analysis of left ventric-
ular function and coronary arteriograms for each patient .
The criteria for classifying a patient as a candidate for
potential revascularization in this analysis were as follows :
.ACC Vol. 22, No . 4
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1) the presence of predominantly viably myocardium distal
to a proximal coronary artery occlusion or distal to severe
stenosis of a major infarct-related coronary artery on coro-
nary arteriograms ; 2) an alternative criterion for classifying a
patient as a potential candidate for revascularization vas a
completed transmural infarction or scar with little viability
distal to the corresponding arteriographic disease but severe
proximal stenosis of one or more other major, noninfarct-
related coronary arteries supplying viable myocardium by
rubidium or F-18 fluorodeoxyglucose, or both studies with or
without normal contraction on left ventricular angiograms of
those noninfarct-related areas .
To further clarify specific patients as potential candirates
(or not) for revascularization, we used the following addi-
tional criteria for exclusion from potential mechanical inter-
vention: 3) a completed infarction with little residual viable
myocardium distal to a coronary occlusion or the most
severe stenosis ; 4) well collateralized myocardium distal to
all significant stenoses or occlusions proximal to viable
myocardium with collateral flow rising from coronary arter-
ies free of significant narrowing in association with normal
ventricular function and absence of refractory exe1 tional
angina; 5) an additional conservative alternative, potential
exclusion from intervention, was single-vessel right, diago-
nal or obtuse marginal disease (non-left anterior descending
coronary artery) with a normal ejection fraction and predom-
inantly viable myocardium distal to the infarct-related ste-
nosis, which met criterion I for potential intervention but
was excluded on this more conservative basis (noted by E
[for exclusion from intervention] in Tables l and 5) .
A mix of patients with either recent myocardial infarction
(within I month) or remote myocardial infarction (> l month
after myocardial infarction) were recruited to demonstrate
feasibility in this pilot study of applying PET clinically to the
entire range of patients seen in clinical practice. For similar
reasons, we recruited into the study patients who had
undergone prior coronary bypass grafting or coronary angio-
plasty carried out previously for clinical reasons unrelated to
:md before the PET study . Such patients are commonly seen
in clinical practice and comprise a group essential to the
study design because their infarct-related arteries have been
mechanically reperfused or revascularized . For this study
the status of the bypass grafts or instrumented arteries, or
both, were determined by arteriography (Table 1) and inte-
grated into the analysis of PET data for suitability of further
revascularization. It is important to evaluate the feasibility
of assessing viability in such patients for further potential
revascularization and for assessing mortality risk.
Results
Figure 1 shows the orientation of three-dimensional to-
pographic displays that avoid the visual spatial distortion
inherent in polar displays . Figure 2 illustrates early (upper
row) and late (lower row) images of rubidium in three-
dimensional topographic displays under rest conditions after
YOSHIDA AND GOULD
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a single intravenous injection of rubidium-82
. A severe
inferior defect of moderate size on the early image shows
extensive further washout on the late image with little
rubidium trapping, indicating a completed transmural infe-
rior infarction without remaining viability
. Figure 2B com-
pares the late rubidium image (upper row) with the F-18
fluorodeoxyglucose image (lower row), showing them to be
equivalent .
Figure 3A shows studies from a patient referred with
arteriographic severe three-vessel coronary ortery disease, a
diagnosis of end-stage ischemic cardiomyopathy in chronic
heart failure and a previous recommendation for heart
transplantation as his only treatment option . On the left
ventricular angiogram there was an extensive akinetic ante-
rior left ventricular wall and a large, severe, fixed anterior,
septal and apical defect on thallium scan interpreted as a
fixed transmural scar. The patient had pulmonary edema
immediately on lying down in the PET scanner and required
intravenous furosemide and afterload reduction with nitro-
glycerin to complete the PET study . The early rubidium
image by PET shows moderately reduced anterior and septal
perfusion on the early image with little washout, indicating
substantial rubidium trapping consistent with underperfused
viable myocardium . The apex does not retain rubidium-82,
indicating necrosis of 20% of left ventricular myocardium .
The inferior wall shows greater activity on the late rubidium
image compared with low activity on the early image . This
type V pattern indicates low flow at rest with cumulative
trapping of rubidium in the late image characteristic of some
flow to viable myocardium . Accordingly, revascularization
'"y coronary artery bypass surgery was successfully carried
uat. A follow-up PET study showed normal myocardium
(Fig. 3B), except for a small apical scar and a small linear
lateral abnormality due to a small, severely diseased diago-
nal branch that could not be bypassed . Preoperative ejection
fraction was 32%, increasing to 54% with normal regional
contraction 2 months after bypass surgery . Congestive heart
failure disaprteared .
Table I lots all of the clinical characteristics for each
patient, including case number, automated analysis of infarct
size, visual interpretation of PET images, results of left
ventricular angiography, coronary arteriography with loca-
tion/severity of stenoses, status of grafts, mortality over
3 years and, finally, clinical classification of each patient as
a suitable candidate for potential revascularization on the
basis of PET assessment of viability integrated with appro-
priate coronary anatomy and left ventricular function by the
criteria listed under Methods.
Location and size of myocardial infarction . Eight patients
had single-vessel and 27 patients had multivessel coronary
artery disease. In all 35 patients, location of the myocardial
infarction on rubidium or F-18 fluorodeoxyglucose images,
or both, corresponded to infarct location by coronary arte-
riography, left ventricular angiogram and electrocardiogram .
Five patients who had no or little myocardial uptake
of
F-18 fluorodeoxyglucose anywhere in the heart were dia-
tj flg
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Table 1
. Clinical Characteristics of the Study Patients
I
2 Large RCA
3
I E
I E
3
2
I Colfaterals
I
I
1 .2
3
3
I
"For exempla
. 80130 = previous coronary aagioptasty (MA),
an 80% to a 30% diameter stenosis . Me Figure 4 legend for explanation of A2 to AS and m2.
03.
tSeverity of defect on late rubidium IRbI image and FDG image
: I+ = mild ; 2+ = moderate ; 3+ = severe . §LAD extends to the distal one-third of the
posterior wall . UProxintal anterior and proximal infbrior wall contract nor atlly. I I : different severity of defect in different segments
. A = anterior; Ak = akinesia ;
CABG = coronary artery bypass graft
; D
-
dyskinesia; d = distal; Diag =
nah E = excluded from intervention (a conservative alternatve) on the
basis of single-vessel disease (non-left anterior descending coronary artery ILAD) with normal
ejection fraction IEFI ; FDG = F-18 fluorodeoxyglucose ;
betic, In the 30 patients with interpretable F-18 fluorodeoxy-
glucose images, infarct size on rubidium images was com-
partd with that on F- 18 fuorodeoxyglucose images . In 26 of
these 30 patients there was visual concurrence of infarct size
and location on rubidium and F-l8 fluorodeoxyglucose im-
ages. In four patients the visual size of the infarcted area on
F-111 fluorodeoxyglucose images was larger than that on
rubidium images. In these four patients, the ejection fraction
Based Remote
on Procedure
Criteria Before PET or
in This Clinical
Study Comment
I
E
3
1 .2
I
3,4
112
3 PICA of LAD
I
I E
1 .2
3
1 .2
I E
I Remote CABG
patent, only
RCA at risk
I
4
1 .2
I .
I
I
I Remote CABG
patent, only
diagonal at
risk . E.
JACC Vol . 1.12 . N.. 4
October
1%,1194-97
by left ventricular angiogram was normal, with either no or
modest regional contraction abnormalities, suggesting that
the smaller infarct size by rubidium imaging was more
consistent with the normal ejection fraction and normal left
ventricular function as opposed to the larger infarct size by
F-18 fluorodeoxyglucose imaging. Despite these moderate
visual differences in a few, particularly diabetic, patients,
there was good correlation between infarct size by auto-
Case
No .
Age
(yrY
Gender
Location or
Infarct by
PET
Regional Wall Motion
$fanfare Coronary Artery
f% diameter stenosis)'
Intervention
Indicated for
Ml
Artery
Other
Artery
LAD
Ding LCx OM. RI RCA
Normal Hypokinesia Akinesia
129 44IM X . I
Other I
40m 90p Yes No
936 3WM A, S, X . L I A . L X
. SID) 90p Sop No
No
965 41IM A . X, I S
A
. X .
L I loop loop 73
100 Yes Yes
161 SNF I
Other 1
90p Yes No
915 6SIF
A, S . X Other S A. X(D) SOP
4op
100 No No
916
471N I Other X .I
so 90
(A)p
90P yes. Yes
921 am A, X, L Other L
A. X l0(WSOp trop t3lp
Sop No No
911 SNP A,S,X Other
A, S, X 9Om
Yes No
922 441F L
All
99140 60 Yes No
924 671101 S
. L, I Global
1001,60 100/99 1100 Yes yes
912 33!01 A, S. X. L. I S . L. I A . X loop 90p 99m 99m No No
993 511F A, X Other A . X
93p140 flop Yes Yes
993 S31F I All
60
(~Op
95p/40 Yes No
9#7 611F X . t Mild . global Graft Graft
Graft IOOm No No
91* SIIF
X 90130 Yes No
991 31 IM I Other I loop No No
992 S91M S, X, I Other I 9Op Diffuse
loop 90p Yes Yes
991 621N X, L, I Other A, S,
X 99p 99p
SOP
Yes
'Yes
999 S71M S. X. I All 99p/So 8Op Yes No
1002 SO/M I Other I 30d 90p 93m Yes No
1003 361F I All Graft
SOP
Graft Graft Yes Yes
1005
37101
1 All 60pMpl
50111 Yes No
1010 67/F A. S. X L I A . S. X $5d loop No Yes
1011 34!01 A . S. X. L. I Global imp loop No No
1013
63IM X, I Other A, X 40d loop 90p110 Yes No
1014 O F L Other
L 60m 95p/20 Yes No
1013 WM 15,1.1-X
Other I 60rn loom No No
1016 631F A, S, X, I A, X, 1R 9% 911m
90m 1000 No Yes
1017
ON A, S, X Other A, S. X imp Yes No
1019 74114
A Other A 93p Yes
No
10 80101
A, S . X Other A, S, X IISp 70d Yes No
1031 39101 A, S, X Other A, S, X
1003 90p Yes Yes
1011+ 44/M A, S, X, I Global
loop
SOP
99p No No
1031
SZIM A. S, X Other A. S. X loop
No No
1033 541F A. X
Other pA A. X 99p
Yes No
Infarct Size
M)
Washout
	
lib
Type Severity$ Quant Vis
mated analysis of rub :idium washout images and automated
infarct size on F-1S fluorodeoxyglucose images, with a
regression correlation of r = 0.82 (p < 0.001) and corre-
sponding good visual correlation between rubidium and F-1S
fluorodeoxyglucose images .
There was agreement between blinded readings of the
two observers in 82% of patients. Observer K.Y. and
K.L.G. both changed minor aspects of their interpretations
infarct Size
(FDG) (f of
LV in PET
scan)
3-yr Follow-Up
FDG
Severity Quant Vis PTCAICABG
Died
H -
hypokinesia ; I = inferior ; L = lateral
; LCs = left circumflex coronary artery ; LV = left ventricle ;
M = male ; m = midvessel ; MI artery = artery associated
with myocardial infarction ; N = normal ; ND = not done
; OM = obtuse marginal
; other = the presence of normal contraction of other myocardial segments
;
p = proximal ; pA = proximal anterior, PET = positron emission tomography
; Quant = quantification ; RCA =1 right coronary artery
; RI = ramus intermedius
coronary artery ; S = septal ; U = uninlerpretable owing to lack of heart uptake ; Vis = visualization
; X - apex . See text for description of criteria I through 4
for candidacy (or not) for rm-ascularization .
to a final consensus reading in 3% of studies. K.L.G
. made
minor changes in his interpretation to agree with K .Y
. in 6%
of cases, and K .Y. made minor changes in his interpretation
to agree with K.L.G. in 9% of cases (p = NS) .
Relation of infarct size by positron emission tomography to
left ventricular ejection fraction and contraction patterns
.
Figure 4 demonstrates the relation between infarct size
measured by automated quantitation of rubidium washout
JLCC Vol. 2.:, No. 4
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Table I (continued)
.
1 2+ 14 12 3+
24 20 +
111
3+
54
37 3+ 42
40
+
111 3+ 22 35
3+ 22 40 +
11 2+ 14 10
3+ 19 15 +
IV'
3+-
37 35 3+ 29
35 - ++
III 2+ 14
15
3+
10
15
111 3+ 46 35 3+
32 40 +
11(1) 2+ (1+1 18 10 2+ (I+)
15 10 +
1 1+ 11
3
U
U U
+
II
2+ (I+) I3 12
2+
(1+-)
8 10 + ++
IV 3+. 81 M) 3+
77 55 + +
11 3+ 32 211 U
U U +
It I+ 18 5 U U
U
+
1 1 +
7
10
2+
15 t0
II 1+ 8 10 1+ 7 15 +
11 2+ In 12 2+ 13 18
11
3+ (2+)
U U U U U +
11 111 1+
23 20
1+ 6 20
1 1+ 12 10 1+ 8 10 +
11 3+ 21 20 3+ 22 20 +
1 1+
5 5
1+ 6 5
1 2+
9 8 2+ 7
8
+
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Flgrre 1, Schematic of three dimensional topographic display of
positron ai nission tomography images . The views are iedlcated .
Images compared with left ventricular ejection fraction mea-
sured by angiograms at cardiac catheterization . Infarct size
has a curvilinear inverse relation to ejection fraction. On
average, ejection fraction decreased below normal when
approximately 20% of the ventricle was infarcted or scarred,
as measured by PET. The relation between infarct size and
ejection fraction in individual patients depended not only on
infarct size but also on the location and number of myocar-
dial segments involved. The equation relating myocardial
infarct size (S) automatically determined by PET software to
ejection fraction (F) was S = 130 - 3.9F + 0.032F2 , where
S and F are in percent) . Five patients with a very large
infarct and an ejection fraction <30% all had involvement of
four orall five segments of the heart (anterior, septal, apical,
lateral or inferior areas). Seven patients with the smallest
infarcts and a normal ejection fraction all had involvement of
only one of these myocardial segments, with six of these
patients demonstrating an inferiody located infarct .
There were similar curvilinear relations between ejection
fraction and, infarct size by F-18 fluorodeoxyglucose imag-
ine, with ejection fraction similarly starting to decline at 20%
to 25% of WArct sin. However, because the variability of
P-l8 P 'odeoxyglucose uptake 'kn normal areas of myocar-
dium ^. -its apparent infarct size, particularly in diabetic
patients, there was more scatter in the relation between
ejection fraction and infarct size by F. 18 fluorodeoxyglucose
imaging.
WON of visual rubidium washout type by positron
errtlrsios tomograpby to left ventricular ejection traction and
action patterns. The visual classification of washout
type is a qualitative judgment or interpretation predomi-
neatly reflecting the visual change in intensity of defect or
washout on early to late images (mild, marked) and visual
residual trapping of rubidium on the late image (substantial
or insignificant residual). Figure 5 relates visual rubidium
washout type to ejection fraction by left ventricular angiog-
raphy, again demonstrating good qualitative correspon-
dence. The type V rubidium image reflects the filling in of a
ddect or increasing activity on the late rubidium image
compared with the early image. This pattern indicates low
flow with slow delivery of rubidium but adequate late
trapping by viable myocardium, illustrated in Figure 3 . It is
characteristically seen in myocardium supplied by small-
sized cohateral channels and may be associated with either
small infarcts and good ventricular function or with border
regions of large infarcts and poor ventricular function .
Therefore, in some patients the type V category of rubidium
image did not correlate with infarct size or ventricular
function .
Prognosis based on left ventricular ejection fraction, infarct
size and myocardial viability over 3 years of fbtlow-up. The
cohort of the first 35 patients studied for myocardial viability
by rubidium washout imaging was followed up for an aver-
age of 3 .0 ± 0.3 years (range 2 .8 to 3.9) for mortality.
Because left ventricular ejection fraction is a recognized
prognostic indicator, it was analyzed initially with mortality
determined prospectively for patients with an ejection frac-
tion =43% or >43%. This threshold of ejection fraction was
based on the normal mean ejection fraction ± 2 SD of 55 ±
12% by gated blood pool imaging in our laboratory for
purpove of relating mortality to noninvasive prognostic
indexes. The conservative lower limit of ejection fraction,
being unequivocally abnormal at >95% certainty, was there-
fore 5::% minus 12%, or 43% .
Table 2 shows that in 16 patients with an ejection fraction
>43%, the mortality rate was 6% over 3 years, and in 18
patients with an ejection fraction c43%, it was 38%, a
statistically significant difference (p = 0.029, Fisher exact
test) (27,28) . Therefore, in the entire group of patients, an
ejection fraction s43% predicted high mortality . However,
for patients with an ejection fraction s43%, the average
election fraction of those who died was 30%, and for those
who survived it was 35% (p = NS) . Therefore, for patients
with an ejection fraction s43%, the degree of reduction of
ejection fraction <43% did not predict mortality, as also
shown la Table 2 .
Myocardial infarct size by PET was then examined as a
predictor of mortality . However, one might expect that
ejection fraction would be related to or dependent on infarct
size as the primary variable . Therefore, Figure 4 demon-
strates the relation between infarct size by automated anal-
ysis of rubidium washout images compared with ejection
fraction by left ventricular angiograms at cardiac catheter-
ization . To examine infarct size as a prognostic indicator, a
threshold myocardial infarct size corresponding to an ejec-
tion fraction of s43% was determined from Figure 4 and the
equation S = 130 -- 3.9F + 0.032F2, where S is infarct size
by PET and F is ejection fraction . For an ejection fraction
s43%, which is the ejection fraction threshold for predicting
high mortality, the corresponding infarct size is X23%,
based on the observed correlation . Therefore, the threshold
of infarct size for correlation with mortality was a23% of the
left ventricle, as determined by PET.
Table 3 shows that the mortality rate over 3 years for
patients with an infarct size or scar <23% of the left ventricle
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Figure 2 . A, Early (upper row)
and late (lower row) positron
emission tomography images of
rubidium-82 showing type III ru-
bidium washout with predomi-
nantly infarcted myocardium or
scar and little remaining trapped
rubidium-82, indicating little
remaining viability. B, Late
rubidium-82 (r) (upper row) and
F-18 fluorodeoxyglucose (fdg)
(lower row) images in the same
patient
. ANT (A) = anterior ; INF
(1) = inferior
; LAT (L) = lateral ;
SEP (S) = septal.
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P
llgure 3. A, Type Il rubidium
washout, a mild large anterior
(ANT) rest perfusion defect in the
early phase image (upper row) and
predominantly rubidium trapping
in the proximal anterior (ANT)
wall, indicating viable myocar-
dium despite akinesia of the ante-
rior wall and an ejection fraction
of 32%. There is washout to a
severe defect with little rubidium
retention, indicating necrosis of
the apex and distal anterior distri-
bution. B, Normal positron emis-
sion tomography scan after revas-
cularization, with normal regional
left ventricular contraction and an
ejection fraction of 54% and only
asmall residual apical defect
. Ab-
breviations as in Figure 2
.
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Figure 4, Relation of left ventricular (LV) ejection fraction (F) and
infarct size (S) based on automated measurements in software front
serial rubidium (RB-82) images. The combined lelterlnumber sym-
bols refer to the number of regions (of five) involved in the
infarction . Al, 2, 3 = onc, two or thre regions involved in the
infarction such as inferiorilateral, including anterior areas ; A4,5 =
four
or five regions involved in the infarct including, inferior, lateral,
septal and apex (X), in addition to anterior areas ; m2 and m3 = two
or three multiple regions other than anterior ; other abbreviations as
in Figure 2.
was 5.0% compared with a mortality rate of 43% for patients
with an infarct size or scar ?23% of the left ventricle, a
significant difference (p = 0 .014, Fisher exact test) (27,28) .
In the group of patients with infarct size z23%, the average
infarct size in those who died was 48% and 40% in those who
survived (p = NS) . Therefore, for the group with infarct size
z23%, the size of infarct or scar >23% did not predict
mortality .
Thus, both low ejection fraction and large infarct size
predicted high mortality . However, within the
subgroups
Figure 5 . Left ventricular (LIT) ejection fraction related to rubidium
(Rb) washout type on serial rubidium images . Type of rubidium
washout ranges from mild (type 1) . indicating substantial viability, to
severe defects (type IV), indicating necrosis .
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Table 2. Ejection Fraction and Mortality Over 3 Years
Mortalit_'
EF Deaths Rate
>43% Ills 6%
s43% 6/16 38%
p Value
EF e.43% EF n
(unpaired t test)
Alive 35% 10 NS
Dead
30%
6 NS
EF = ejection fraction
.
with a low ejection fraction (<43%) or large infarct size
(323%), ejection fraction and infarct size did not predict
mortality . Therefore, in the subgroup with an ejection frac-
tion s43%, we examined myocardial viability by PET in
arterial risk zones suitable for revascularization by arteriog-
raphy as a predictor of mortality .
Table 4 shows that in the subgroup with an ejection
fraction -4,%, patients with remaining viable myocardium
suitable for revascularization had a 3-year mortality rate of
13% compared with 63% in patients without viable myocar-
dium in the arterial zone at risk (p = 0.059, the Fisher exact
test) (27,28) . Thus, there was only a 5 .9% probability that
this difference could have occurred by chance alone (i . e ., a
5.9% probability that only one death could have occurred by
chance alone in the subgroup with nonviable myocardium .
Therefore, the presence of myocardial viability in the arterial
risk zone was a strong, and the only, predictor of survival,
and absence of viability in the arterial risk zone was a strong,
and the only, predictor of mortality in patients with an
ejection fraction s43% . In addition, in the group with an
ejection fraction s43%, there was no significant difference
over 3 years between infarct size in those who survived and
those who died. Therefore, in this group with impaired
ejection fraction, infarct size did not predict mortality ; only
the presence (or absence) of myocardial viability predicted
mortality .
We then examined the value of myocardial viability in the
arterial zone at risk for predicting mortality during the 3-year
follow-up period in all 35 patients, not just those with an
ejection fraction s43% (Table 4) . In
all 35 patients (including
Table 3
. Infarct Size by Positron Emission Tomography and
Mortality Over 3 Years
p Value
(Fisher exact test)
0 .029
LV = left ventricle
.
Infarct Size
(% of LV)
M.~.
Deaths
Mortality
Rate
P Value
(Fisher exact test)
<23%
1/19 5%
0.014
923%
6/14
43%
Infarct Size z23% Size
n
p Value
(unpaired r test)
Alive
40% 8
NS
Dead
48%
6
NS
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Table 4
. Myocardial Viability by Positron Emission Tomography
in Arterial Zone at Risk and Mortality Over 3 Years
All Patients
EF
-
*ctloa fraction,
those with a low ejection fraction) with viable myocardium
in arterial zones at risk, the mortality rate was 8% compared
with 50 (5 of 10) in the group with no remaining viable
myocardium in the arterial zones at risk . This difference is
significant (p
-
0.018, the Fisher exact test) (27,28) .
Thus, in all patients or in those with a low ejection
fraction (s43%) or with a large infarct/scar (z23%), myo-
cardial viability (or nonviability) in arterial zones at risk by
PET was a good predictor of mortality or survival over
3 years. By comparison, within the group with a low ejection
fraction or large infarct size, the extent of low ejection
fraction or large infarct size was not predictive of mortality,
but myocardial viability was . In all 26 patients with myocar-
dial viability, the mortality rate in those with an ejection
fraction x43% (mean ejection fraction 53%) was 6% (1 of
18), and in those with an ejection fraction <43% (mean
ejection fraction 37%) the mortality rate was 13% (1 of 8)
(p
-
NS). Therefore, in the subgroup with retraining myo-
cardial viability in arterial zones at risk, ejection fraction was
not predictive of mortality because survival in the whole
group was good regardless of ejection fraction.
Table 5 summarizes the proportion of those postinfarc-
tion patients with viable myocardium suitable for revascu-
larizadon on the basis of rubidium PET and appropriate
coronary arteriographic anatomy and clinical status . Nine-
teen (54%) of 35 patients with myocardial infarction were
suitable candidates for revascularization on
the basis of
Table 6. Sultaible Candidates for Coronary Angioplasty or
Corotnuy Artery Bypass Crafting Based an Positron
Emission Tomography
(El = as a conservative ante
:native, cauid be excluded fnan intervention
based on
stele-vend
(not left anterior descending ILADD coronary artery
disuse (CAD) with normal ejection fraction
.
remaining myocardial viability by PET and suitable coronary
arteriographic anatomy (Table 5) . Figure 6 schematically
summarizes the patterns of myocardial viability in relation to
coronary artery disease . Approximately 31% of 35 patients
were appropriate candidates for revascularization on the
basis of substantial viable myocardium remaining in the
infarct area without other risk zones (20%) or in addition to
other risk zones (11%) . Another approximately 23% of
patients were appropriate candidates for revascularization
on the basis of a proximal stenosis and viable myocardium
proximal to the infarct area (but not in the infarct defect) or
in other risk zones in the distribution of other arteries
unrelated to the infarct. Approximately 46% of 35 patients
with myocardial infarction did not need revascularization on
the basis of completed infarcts with no more viable myocar-
dium at risk distal to significant stenoses (29%) or on the
basis of single-vessel, non-left anterior descending artery,
coronary disease with normal ejection fraction (17%) .
Table 6 compares clinical decisions actually made for or
against revascularization during the 3-year period compared
with the potential alternative decision based on PET results
at entry into the study . The criteria for potential alternative
interventional decisions based on PET took the conservative
approach of excluding from revascularization patients with
Flgure 6. Schematic diagram summarizing the percent of patients
with myocardial infarction that were and were not suitable candi-
dates for coronary angioplasty or coronary artery bypass surgery on
the basis of combined positron emission tomography-arteriographic
analysis. For this scheme, n = 35. and all percents listed are a
percent of 35. CAD = coronary artery disease ; LAD = left anterior
descending coronary artery.
46% NO INTERVENTION
•
Complete Infarct . No Risk Zones (29%)
• Single vessel CAD. Non-LAD (17%)
[~ Normal, Viable
® Necrosis
Mixed with Remaining Viability
31% INTERVENTION BASED ON
Remaining Viability In Defect and
• No Other Risk Zones (20%)
•
Plus Other Risk Zones (11%)
23% INTERVENTION BASED ON
• Proximal Viability or
• Other Risk Zones
Myocardium at Risk
Mortality
Deaths Rate
P Value
(Fisher exact test)
Viable
7125 8% 0.018
Not viable 5/10
50%
Patients With EF 943%
Viable 118 13%
0.059
Not viable 5l8 63%
No.
96
lnfarct-relied artery
LAD aadler muttivessel CAD
17135
49
Shale vessel CAD (E)
635 17
NoidialkcNew
arteries
only
2135 6
Both
iabroWeleted
and other arteries
LAD sailor nudtivessd CAD
19135
54
Se
-vaW. aot LAD (E)
6135
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Table 6. Revascularization After Myocardial Infarction Compared
With Ideal Based on Positron Emission Tomographic Viability
and Coronary Arteriography
: 3-Year Follow-Up
69%(24/35) Post-Ml patients who had PTCA/CABG
54%(19/35) Patients optimal for PTCA/CABG based on
viability*
37%(13/35) Patients who needed alternative opposite decision
about revascularization based an PET
*Excludes single-vessel, non left anterior descending artery disease from
PTCA/CABG . Abbreviations as in Table
I .
single-vessel coronary artery disease not involving the left
anterior descending artery (Cases 829, 922 . 985, 1003, 1013,
1014 designation by an E for exclusion in Tables I and 5) .
On the basis of PET integrated with arteriographic anal-
ysis by the criteria listed under Methods, an appropriate
decision for or against potential revascularization consistent
with PET, arteriographic and clinical data was made in 22
(63%) (Table 6: 15 yes + 7 no) of 35 patients in the study . A
clinical decision that was not consistent with PET viability
data was made in 13 (37%) (Table 6 : 9 no + 4 yes) of 35
patients. Thus, if used as the basis for a decision with regard
to revascularization, PET would in retrospect have resulted
in an alternative, opposite interventional decision in 13
(37%) of 43 of patients with myocardial infarction, as sum-
marized in Table 6.
Table 7 shows mortality for the patients with or without
myocardial viability in the arterial zone at risk with or
without revascularization . Of patients with remaining viable
myocardium in arterial zones at risk, 80% had revascular-
ization over the 3-year follow-up period and a low 3-year
mortality rate of 8%, including those with an ejection frac-
tion above and below <43% . By comparison, in patients
with completed infarction or scar without remaining viability
in the arterial zone at risk, 40% had revascularization and a
high 3-year mortality rate (50%) in both the revascularization
and nonrevascularization groups.
In the subgroup of patients with an ejection fraction s43%,
those with viable myocardium in the arterial zone at risk had a
mortality rate of 13%, and 75% had revascularization. For
patients with an ejection fraction X43%, those without viable
myocardium and only scar in the arterial zone at risk had a
Table 7. Myocardial Viability by Positron Emission Tomography
and Risk of Revascularization or Mortality : All Patients
V+ = viable myocardium ; V - = nonviable myocardium
; R+ = reves-
cularized; R- = not revascularized .
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mortality rate of 63%, which was > 13% (p = 0
.059); 50% had
revascularization despite the absence of viable myocardium in
arterial zones at risk, with no difference in mortality between
those with or without revascularization.
Discussion
Our results demonstrate that in a cohort of patients with
recent or old myocardial infarction followed up for 3 years
after PET, the size of myocardial infarction or scar and the
presence of viable myocardium in arterial zones at risk using
generator-produced rubidium-82 were highly predictive of
mortality over the 3-year follow-up . For patients with re-
duced left ventricular ejection fraction (s43%) or large
infarct/scar (>23% of the left ventricle), mortality over the
next 3 years was high . Left ventricular ejection fraction was
highly correlated with size of infarct or scar. Because size of
infarct or scar determines ejection fraction, the size of
infarct or scar by PET is a basic, primary prognostic
indicator that explains the association of impaired ejection
fraction with reduced survival.
Within the subset of patients having a reduced ejection
fraction of s43%, the average ejection fraction in those who
died was not different from that of patients who survived .
Therefore, for this group with a low ejection fraction, the
degree of ejection fraction impairment did not predict mor-
tality . However, the presence of viable myocardium in the
arterial zone at risk predicted survival, and the absence of
viable myocardium in the arterial zone at risk predicted a
high mortality rate. Similarly, for the subset of patients with
large infarct/scar ?23% of the left ventricle, the average size
of infarct/scar in those who died was not significantly differ-
ent from that in those who survived . Therefore, in the group
with a large infarct/scar, the size of infarct/scar was not a
prognostic indicator. However, in this subset, viable (or
nonviable) myocardium in the arterial zone at risk was a
good prognostic indicator of mortality .
In a comparable data base of 82 patient-years of follow-
up, Eitzman et al . (9) reported a 50% mortality rate in
patients who had remaining viable myocardium after myo-
cardial infarction but had no revascularization . In our study
80% of patients (all but five) with remaining viable myocar-
dium in arterial risk zones had revascularization with a
subsequent low 3-year mortality, thereby suggesting sub-
stantial benefit of revascularization in patients with viable
myocardium at risk. Other differences between these two
studies include our use of generator-produced rubidium-82,
automated quantitation of infarct size, the relation of infarct
size to ejection fraction and longer follow-up of 3 years . In
addition, patients in our study with no remaining viable
myocardium in arterial zones at risk and completed infarc-
tion had a high mortality rate (50%) either with or without
revascularization, which therefore did not improve survival
.
In this subset, identified by PET, revascularization was
unnecessary and could have been avoided without affecting
clinical outcome . However, this subset was small, and
V+, R+ V+, R- V-, R- V-, R+
Total
Patients (no.) 20
5 6 4 35
Deaths (no .)
2 0 3
2 7
Indicated
by PET Done Not Done Total
Yes 15 4 19
No*
9 7
16
Total 24 I I 35
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further studies would be needed to determine whether mor-
tality was even higher in patients with revascularization with
no remaining myocardial viability in arterial zones at risk .
Our study conservatively indicates that 54% of patients with
myocardial infarction have sufficient remaining viable myo-
cardium, appropriate coronary arteriograms and clinical
statuss to warrant consideration of revascularization by cor-
onary angioplasty or bypass surgery (Table 5, Fig . 6) .
Currently, revascularization commonly follows myocar-
dial infarction on the basis of clinical criteria or judgments that
are not specific for necrosis or viability of poorly functioning
myocardial segments, As shown in Table 7, our data suggest
that intorventional decisions based on assessing myocardial
infarct size and viability by PET are not likely to increase or
decrease the number of interventions performed in postinfarc-
don patients but would potentially change the selection of
which patients should undergo intervention (or not) in up to
37% of cases based on 3-year follow-up. By comparison . data
of Eitzman et al . (9) showed that 39% of patients had revaseu-
larization decisions inconsistent with PET viability data (8).
Therefore, assessing myocardial infarct size and viability by
PET in relation to the coronary arteriogram and left ventricular
ejection fraction appears to be useful for evaluating postinfarc-
tion patients for potential revascularization .
Together, myocardial viability by PET and infarct or scar
size are better prognostic indicators of mortality than is left
ventricular ejection fraction because in patients with an ejec-
tion fraction X43%, the ejection fraction value did not predict
mortality. For patients with a low ejection fraction, viable (or
nonviable) myocardium by PET in the arterial zone at risk
predicts mortality/survival and identifies patients who are likely
to benefit from revascularization and those who have high
mortality that is not altered by revascularization .
fvWAU&M of the study . Studies with mortality as an end
pant usually require large populations or cohorts of patients
to achieve statistical significance . However, we have previ-
ously shown that for quantitative, highly specific measures
of a pathophysiologic process as an end point, smaller
populations of patients may provide statistical significance
(29,30). For example, for following up the effect of choles .
terol lowering on coronary artery disease, a relatively small-
sized cohort of patients provided statistically significant
differences between control subjects and treated groups if
the end points measured were specific for the pathophysio-
logic process involved, such as severity of coronary artery
stenoses by quantitative coronary arteriography accounting
for the integrated geometric dimensions of percent narrow-
ing, absolute lumen diameter and integrated length effects
for following up progression or regression of coronary artery
stenoses (29,30). Although the cohort in the current study is
small, the long-term follow-up and the quantitative, highly
specific pathophys01ogic information provided by PET for
Ow-4 individual patient yield statistically significant predic-
tions of survival
. Our study is also comparable to a previous
report using comparable technology (9) in patients-years of
%V,ow-up.
Myocardial viability. The original report from this labo-
ratory in experimental animals describing the concept of
rubidium washout as a measure of myocardial necrosis used
continuous time-activity washout curves derived from epi-
cardial radiation detectors (22,23), now confirmed by others
(17,18). This concept of rubidium washout by PET is approx-
imated by our simplified two-image sequence (15,16), which
has been published as equivalent to F-18 fluorodeoxyglucose
imaging for identifying infarcted/viable myocardium as a
routine clinical procedure (15) . There are several dispdvan-
tages of an approach based on multiple serial PET images for
measuring rubidium washout constants . The infarct area,
especially with reperfusion or partial or intermittent occlu-
sion, such as after thrombolysis, is characterized by a range
of mixed necroticiviable myocardium ranging from total
transmural necrosis progressing radially to normal myocar-
dium. Consequently, there is an entire family of rubidium
washout time-activity curves with no single curve character-
izing the area. For clinical decisions it is essential to measure
the percent of myocardium that is predominantly necrotic or
viable . This task is accomplished objectively and automati-
cally by our two-image threshold technique, which divides
myocardium into areas that are predominantly transmurally
necrotic or predominantly viable, as previously validated in
humans by comparison with F-18 fluorodeoxyglucose imag-
ing (15) . By this method the percent of necroticlviable
myocardium can be expressed as a single quantitative num-
ber for comparison with clinical outcomes or with left
ventricular function .
Initial reports suggest that thallium reinjection imaging
improves identification of viable myocardium in stress-
induced perfusion defects, comparable to that obtained with
PET using F-18 fluorodeoxyglucose (24) . However, subse-
quent reports suggest that thallium reinjection imaging re-
mains less sensitive than PET for identifying viable myocar-
dium (31). Particularly after reperfusion, size of myocardial
infarctions by thallium reinjection imaging showed no corre-
lation with left ventricular function (32) . Accordingly, our
study describes the first quantitative relation between infarct
size by imaging, myocardial viability, ejection fraction and
3-year mortality in humans.
Quantitation of positron emission tomography . Like any
automated sizing method in nuclear cardiology, the accuracy
of automated quantitative sizing of infarct and zone at risk
depends on image quality . Quantitative numbers from PET
images must make sense in the overall clinical context,
including visual interpretation. Isolated laboratory values or
quantitative numbers out of clinical context need to be
regarded with caution and skepticism as a basis for major
intervention decisions. Conversely, visual interpretations
involving judgment tend to lack quantitation and objectivity
while being clinically useful. Our viewpoint is that auto-
mated computer analysis of PET images provide objective
quantitation of what the experienced observer sees visually .
However, automated quantitative numbers alone without
corresponding visual interpretation are not sufficient for
JACC Vat . 22, No 4
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major clinical decisions, such as bypass surgery or coronary
angioplasty. Visual interpretation of images alone without
automated quantitation lacks the objectivity that provide the
basis for scientific clinical analysis of data . Thus, both
objective quantitative and visual interpretations are essential
for this kind of analysis .
Conclusions. In a cohort of patients studied for myocar-
dial viability by PET imaging of rubidium washout and
followed prospectively for 3 years, size of myocardial infarc-
tion or scar and myocardial viability in arterial zones at risk
were good prognostic indicators of mortality . Left ventricu-
lar ejection fraction demonstrated a close curvilinear relation
to left ventricular infarct size by PET, with ejection fraction
decreasing significantly to X43% when a23% of the left
ventricle was infarcted or scarred, thereby explaining the
association of shortened survival with reduced ejection
fraction caused by myocardial infarction . For patients with a
low ejection fraction (f-43%) or large infarctslsct :r (?°23 of
the left ventricle), ejection fraction value or infarct size did
not predict mortality . However, for these patients with a low
ejection fraction or a large infarct/scar, the presence of
predominantly viable myocardium in arterial zones at risk
was associated with good survival after revascularization,
and absence of viable myocardium in the myocardial zone at
risk was associated with a high mortality rate that was not
improved by revascularization . These results suggest that PET
imaging is useful in selecting patients for revascularization and
for predicting 3-year mortality, especially in those patients with
impaired ventricular function .
We acknowledge the technical assistance of Mary Jan: Hess, RN and Ro
Edens and
manuscript preparation by Patsy Kleypas .
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